Abstract
Cervical cancer is the second most frequent cause of female cancer mortality and remains a major health problem in women worldwide. Surgery, chemotherapy and radiotherapy alone or combined are the three treatments methods commonly used to treat this disease. However, a significant proportion of the cancer patients still experiences recurrence and eventually dies. Recently, the research advances in molecular profiling and genomics have revealed that the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in mediating multiple cellular functions including cell growth, proliferation, metabolism, survival and angiogenesis. Thus, targeting this signal pathway offers a promising perspective for cervical cancer therapy. In this article, we review the published data from both basic and clinical studies showing that the concurrent cervical cancer chemoradiotherapy dramatically improves the local control of this disease and overall survival by triggering tumor cell apoptotic pathways via the PI3K/AKT/mTOR signalings, proving that the PI3K/AKT/mTOR pathway is one of the most important targets for cervical cancer therapy. We also highlight that several phytochemicals strongly inhibit proliferation of the cervical cancer cells and induce apoptosis by targeting one or multiple molecules through the PI3K/AKT/mTOR pathway. While some of these phytochemicals have been used as therapeutic agents or chemoradiotherapy sensitizers, others are currently in clinical development to be the potential therapeutic agents for the advanced cervical cancer therapy.
Keywords: Cervical cancer, chemoradiotherapy, chemoradiosensitizers, growth factors, notch signalings, phytochemicals, PI3K/AKT/mTOR signalings, PI3K inhibitors.
Current Cancer Drug Targets
Title:Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Volume: 13 Issue: 2
Author(s): Jianghong Wu, Chen Chen and Kong-Nan Zhao
Affiliation:
Keywords: Cervical cancer, chemoradiotherapy, chemoradiosensitizers, growth factors, notch signalings, phytochemicals, PI3K/AKT/mTOR signalings, PI3K inhibitors.
Abstract: Cervical cancer is the second most frequent cause of female cancer mortality and remains a major health problem in women worldwide. Surgery, chemotherapy and radiotherapy alone or combined are the three treatments methods commonly used to treat this disease. However, a significant proportion of the cancer patients still experiences recurrence and eventually dies. Recently, the research advances in molecular profiling and genomics have revealed that the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in mediating multiple cellular functions including cell growth, proliferation, metabolism, survival and angiogenesis. Thus, targeting this signal pathway offers a promising perspective for cervical cancer therapy. In this article, we review the published data from both basic and clinical studies showing that the concurrent cervical cancer chemoradiotherapy dramatically improves the local control of this disease and overall survival by triggering tumor cell apoptotic pathways via the PI3K/AKT/mTOR signalings, proving that the PI3K/AKT/mTOR pathway is one of the most important targets for cervical cancer therapy. We also highlight that several phytochemicals strongly inhibit proliferation of the cervical cancer cells and induce apoptosis by targeting one or multiple molecules through the PI3K/AKT/mTOR pathway. While some of these phytochemicals have been used as therapeutic agents or chemoradiotherapy sensitizers, others are currently in clinical development to be the potential therapeutic agents for the advanced cervical cancer therapy.
Export Options
About this article
Cite this article as:
Wu Jianghong, Chen Chen and Zhao Kong-Nan, Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer, Current Cancer Drug Targets 2013; 13 (2) . https://dx.doi.org/10.2174/1568009611313020004
DOI https://dx.doi.org/10.2174/1568009611313020004 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Concepts in the Development of Platinum Antitumour Drugs: An Update
Medicinal Chemistry Reviews - Online (Discontinued) A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets Management of Fallopian Tube Cancer
Reviews on Recent Clinical Trials The Views of Young Women on HPV Vaccine Communication in Four European Countries
Current HIV Research Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)
Current Pharmaceutical Design RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science Radiolabelling of Ascorbic Acid: A New Clue to Clarify its Action as an Anticancer Agent?
Current Radiopharmaceuticals Imaging Tumor Metastases with Molecular Probes
Current Pharmaceutical Design Targeting Protein Kinase Inhibitors with Traditional Chinese Medicine
Current Drug Targets Bestatin as an Experimental Tool in Mammals
Current Drug Metabolism Synthesis and Evaluation of Antioxidant and Cytotoxicity of the N-Mannich Base of Berberine Bearing Benzothiazole Moieties
Anti-Cancer Agents in Medicinal Chemistry EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets LPA and its Analogs-Attractive Tools for Elucidation of LPA Biology and Drug Development
Current Medicinal Chemistry Cystic Hygroma with Multiple Benign Bone Lymphangiomas in an Adult Patient: A Rare Entity in the Differential Diagnosis of Multiple Osseous Lesions in Oncology Practice
Current Medical Imaging New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias
Current Cancer Drug Targets Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Current Drug Targets <i>In Vivo</i> Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice
Anti-Cancer Agents in Medicinal Chemistry The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry